Latest News & Updates
Breaking News
6 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
FibroBiologics Files Patent for Oral Fibroblast Delivery System Targeting GI Tract Diseases
FibroBiologics files a USPTO provisional patent for an oral fibroblast delivery platform using multilayer encapsulation and pH-sensitive coatings targeting GI diseases.
Pharma Now Editorial Team
Dogwood Therapeutics Launches Halneuron 12-Week CINP Extension Study Ahead of Phase 3 Start
Dogwood Therapeutics opens a 12-week Halneuron® CINP extension study, targeting an end-of-Phase 2 FDA package ahead of a planned 2027 Phase 3 start.
Pharma Now Editorial Team
Medix Biochemica Commits $5 Million to Recombinant Antigen Expansion Across Two Sites by 2030
Medix Biochemica commits $5M to recombinant antigen expansion across Finland and Missouri, targeting 60+ validated products by 2030.
Pharma Now Editorial Team
Viatris Gains FDA NDA Acceptance for Fast-Acting Meloxicam in Moderate-to-Severe Acute Pain
FDA accepts Viatris NDA for fast-acting meloxicam in acute pain, setting a PDUFA date of December 27, 2026.
Pharma Now Editorial Team
